Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.

Anastasopoulou, Stavroula; Nielsen, Rikke Linnemann; Als-Nielsen, Bodil; Banerjee, Joanna; Eriksson, Mats A; Helenius, Marianne; Heyman, Mats M; Johannsdottir, Inga Maria; Jonsson, Olafur Gisli; MacGregor, Stuart; Mateos, Marion K; Mayoh, Chelsea; Mikkel, Sirje; Myrberg, Ida Hed; Niinimäki, Riitta; Schmiegelow, Kjeld; Taskinen, Mervi; Vaitkeviciene, Goda; Warnqvist, Anna; Wolthers, Benjamin; Harila-Saari, Arja; Ranta, Susanna

Anastasopoulou, Stavroula; Nielsen, Rikke Linnemann; Als-Nielsen, Bodil; Banerjee, Joanna; Eriksson, Mats A; Helenius, Marianne; Heyman, Mats M; Johannsdottir, Inga Maria; Jonsson, Olafur Gisli; MacGregor, Stuart; Mateos, Marion K; Mayoh, Chelsea; Mikkel, Sirje; Myrberg, Ida Hed; Niinimäki, Riitta; Schmiegelow, Kjeld; Taskinen, Mervi; Vaitkeviciene, Goda; Warnqvist, Anna; Wolthers, Benjamin; Harila-Saari, Arja; Ranta, Susanna.

Affiliation

Anastasopoulou S; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm. stavroula.anastasopoulou@ki.se.
Nielsen RL; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark; Present address: Novo Nordisk Research Centre Oxford, Oxford, OX3 7FZ.
Als-Nielsen B; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen.
Banerjee J; Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Helsinki University Hospital and Helsinki University, Helsinki.
Eriksson MA; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Neuropediatric Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm.
Helenius M; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby.
Heyman MM; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm.
Johannsdottir IM; Department of Pediatric Hematology/Oncology, Oslo University Hospital, Oslo, Norway.
Jonsson OG; Department of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland.
MacGregor S; QIMR Berghofer Medical Research Institute, Brisbane.
Mateos MK; Kids Cancer Centre, Sydney Children's Hospital Randwick, Sydney, Australia; School of Clinical Medicine, Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW MEDICINE and HEALTH, UNSW Sydney; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney.
Mayoh C; School of Clinical Medicine, Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW MEDICINE and HEALTH, UNSW Sydney; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney.
Mikkel S; Department of Hematology and Oncology, University of Tartu, Tartu.
Myrberg IH; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm.
Niinimäki R; Department of Children and Adolescents, Oulu University Hospital and University of Oulu, PEDEGO Research Unit, Oulu.
Schmiegelow K; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen.
Taskinen M; Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Helsinki University Hospital and Helsinki University, Helsinki.
Vaitkeviciene G; Children's Hospital, affiliate of Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius.
Warnqvist A; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm.
Wolthers B; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen.
Harila-Saari A; Department of Women's and Children's Health, Uppsala University, Uppsala.
Ranta S; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm.

Haematologica ; 107(10): 2318-2328, 2022 10 01.

Article de En | MEDLINE | ID: mdl-35354251

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B et T / Leucoencéphalopathie postérieure Type d'étude: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Oceania Langue: En Journal: Haematologica Année: 2022 Type de document: Article Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google